A detailed history of Bellevue Group Ag transactions in Glaukos Corp stock. As of the latest transaction made, Bellevue Group Ag holds 55,926 shares of GKOS stock, worth $7.17 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
55,926
Previous 55,926 -0.0%
Holding current value
$7.17 Million
Previous $5.27 Million 25.51%
% of portfolio
0.11%
Previous 0.08%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$76.4 - $96.33 $4.27 Million - $5.39 Million
55,926 New
55,926 $5.27 Million
Q4 2021

Feb 10, 2022

SELL
$40.27 - $56.99 $5.79 Million - $8.2 Million
-143,870 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$47.43 - $84.23 $16.7 Million - $29.6 Million
-351,562 Reduced 70.96%
143,870 $6.93 Million
Q2 2021

Aug 12, 2021

BUY
$73.06 - $97.7 $444,935 - $594,993
6,090 Added 1.24%
495,432 $42 Million
Q1 2021

May 12, 2021

BUY
$70.43 - $97.42 $2.82 Million - $3.9 Million
40,010 Added 8.9%
489,342 $41.1 Million
Q4 2020

Feb 16, 2021

SELL
$48.9 - $75.26 $3.25 Million - $5 Million
-66,422 Reduced 12.88%
449,332 $33.8 Million
Q3 2020

Nov 16, 2020

BUY
$37.23 - $50.97 $816,937 - $1.12 Million
21,943 Added 4.44%
515,754 $25.5 Million
Q2 2020

Aug 13, 2020

BUY
$28.78 - $46.83 $2.34 Million - $3.8 Million
81,188 Added 19.68%
493,811 $19 Million
Q1 2020

May 14, 2020

BUY
$25.53 - $70.14 $267,426 - $734,716
10,475 Added 2.6%
412,623 $12.7 Million
Q3 2019

Nov 14, 2019

BUY
$58.58 - $83.91 $17.3 Million - $24.7 Million
294,913 Added 275.02%
402,148 $25.1 Million
Q2 2019

Aug 14, 2019

BUY
$63.59 - $78.71 $6.82 Million - $8.44 Million
107,235 New
107,235 $8.09 Million
Q2 2018

Aug 07, 2018

SELL
$27.62 - $44.51 $828,600 - $1.34 Million
-30,000 Closed
0 $0
Q3 2017

Nov 13, 2017

BUY
$31.26 - $42.03 $234,450 - $315,225
7,500 Added 33.33%
30,000 $990,000
Q2 2017

Aug 14, 2017

BUY
N/A
22,500
22,500 $933,000

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $6.11B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Bellevue Group Ag Portfolio

Follow Bellevue Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.